For information and resources regarding returning to campus and COVID-19 please visit the university COVID-19 website

Curated Collisions Series

Hindsight is 2020
Health and Life Science Transformations in 2021
and Beyond

December 10, 2020
1 – 4 PM, Online

REGISTER NOW

The Curated Collisions Series will kick off with a 3-hour online event this December 10th, convened by Northeastern University’s Health Sciences Entrepreneurs Program and the Bouvé College of Health Sciences.

Join leaders from industry and academia who will share their perspectives and approaches to solving the complex problems faced today in health and life sciences, while building relationships and collaborations around grand health challenges.

Collide with CEOs, SVPs, VPs, Directors, and Managers from pharmaceutical, biotechnology, medical device, healthcare, and higher education organizations.

  • share

Speakers

Evan Falchuk — Speaker at Curated Collisions Northeastern University

Evan Falchuk
Chairman and CEO
Village Plan

Evan Falchuk is a business and political entrepreneur focused on creating a better future. He currently serves as the CEO of VillagePlan, a company that helps people navigate the challenge of caring for an aging loved one. From 1999-2013, Evan was Vice-Chairman and President of Best Doctors, Inc. and co-led its growth to 600 employees and serving over 75 million people. Best Doctors is a global healthcare company and the pioneer in getting patients the right diagnosis and treatment through expert medical consultants and novel insurance. It was sold to Teledoc Health for $440 million in 2017.

In 2014, Evan founded the United Independent Party and ran as its candidate for Massachusetts governor. Evan began his career as an attorney and serves on the steering committee of Lawyers Defending American Democracy, a nationwide coalition of lawyers spotlighting abuses of power and calling on the legal profession to act to protect the rule of law.

Stas Gayshan, CIC

Stas Gayshan
General Counsel CIC Health.
Managing Director CIC)

Stas has experience and expertise at the intersection of entrepreneurship, technology, law, and politics.

Jen Horonjeff — Speaker at Curated Collisions Northeastern University

Jen Horonjeff, PhD
Founder and CEO
Savvy Cooperative

Jen Horonjeff, PhD, is a patient advocate and the founder & CEO of Savvy Cooperative, the first and only patient-owned co-op that helps innovators connect directly with diverse patients in order to get the insights they need to build better and more inclusive healthcare solutions. Jen was named one of the 50 Most Daring Entrepreneurs of 2018 by Entrepreneur Magazine, alongside the likes of Elon Musk, Chance the Rapper and Reese Witherspoon for her work at Savvy. She grew up with multiple autoimmune conditions and survived a brain tumor as an adult, and is also a patient-centered outcomes researcher, a human factors engineer, and an FDA advisor. Utilizing her unique perspective, Jen strives to give patients a platform to have their experiences be heard, included, and equitably valued–because the future of healthcare is co-designed with patients.

Satish Tadikonda
Executive Fellow in Entrepreneurship at the Rock Center, Harvard Business School

Satish Tadikonda is an entrepreneur in the life sciences and healthcare sectors. His current venture, Avigo, focuses on using healthcare information to optimize clinical trials. In addition to his current venture, Satish is an Executive Fellow in Entrepreneurship at the Rock Center for Entrepreneurship at Harvard Business School, and also serves as an Executive Partner of Blue Cloud Ventures, a growth equity fund. Prior to Avigo, Satish was the Founder/CEO of Virtify, Enmed and Tribiosys, all focused on the Life Sciences R&D software and services space.

In addition to founding startups and serving as a member of the board of directors of several venture-backed companies, Satish is an active early stage investor and is a member of TiE Angels, TBD Angels, and Sky Ventures. He helped co-found TiE ScaleUp and is deeply involved in working with many startups. At ScaleUp and through other mentoring activities at Mass Challenge and the Harvard iLab, Satish advises a number of startups, including helping companies overcome typical barriers to growth by optimizing their strategic positioning, business model, operations, sales and competitive advantage.

Satish holds a Doctorate in Electrical and Computer Engineering with a focus on medical imaging

Agenda

The format will consist of 3-4 plenary talks to get us started followed by 3 parallel track breakout sessions at which attendees have an opportunity to network with operators and thought leaders from industry, business, medical, and academic spheres of influence around broad topics related to the state of health and intersections with life science today and the opportunities and challenges for the future. The final session will bring attendees back together to share takeaways and next steps.

Plenary Sessions
1:00 – 2:00 PM Lightning Talks
Curated Collisions Sessions
2:00 – 3:30 PM Breakout Sessions
Curated Collisions Sessions
3:30 – 4:00 PM Breakout Sessions

TOPICS

  • Drug discovery, development, and delivery and the FDA approval process of how to launch a new drug in our current environment
  • AI and deep learning in drug development
  • Diagnostics and early detectors of disease
  • The impact of technology on the delivery of healthcare in the changing world
  • Data and analytics: payers, providers and life sciences
  • Health science and life science working together to create resilience across the health span
  • Eliminating global health disparities and creating health equity
  • Challenges and opportunities in digital therapeutics

The format will consist of 3-4 plenary talks to get us started followed by 3 parallel track breakout sessions at which attendees have an opportunity to network with operators and thought leaders from industry, business, medical, and academic spheres of influence around broad topics related to the state of health and intersections with life science today and the opportunities and challenges for the future. The final session will bring attendees back together to share takeaways and next steps.

Plenary Sessions
1:00 – 1:10 PM Opening Remarks
1:10 – 1:20 PM Speaker (Topic)
1:20 – 1:30 PM Speaker (Topic)
1:30 – 1:40 PM Speaker (Topic)
Curated Collisions Sessions
1:40 – 1:50 PM Break – Proceed to breakout rooms
1:50 – 2:20 PM Networking Breakout Session 1 (Topic – 3 parallel sessions, 10 to 15 people in each session)
2:25 – 2:55 PM Networking Breakout Session 2 (Topic – 3 parallel sessions, 10 to 15 people in each session)
3:00 – 3:30 PM Networking Breakout Session 3 (Topic – 3 parallel sessions, 10 to 15 people in each session)
3:30 – 3:50 PM Either a luminary
3:50 – 4:00 PM Wrap-up Gene Tunik

TOPICS

  • Drug discovery, development, and delivery and the FDA approval process of how to launch a new drug in our current environment
  • AI and deep learning in drug development
  • Diagnostics and early detectors of disease
  • The impact of technology on the delivery of healthcare in the changing world
  • Data and analytics: payers, providers and life sciences
  • Health science and life science working together to create resilience across the health span
  • Eliminating global health disparities and creating health equity
  • Challenges and opportunities in digital therapeutics

Sponsors

Interested in sponsoring this event? Learn more.

Sponsor A

Sponsor B

Sponsor C